Werewolf Therapeutics

Oncology biotherapeutics company

Stránky společnosti

Ticker

HOWL.NASDAQ

Trh

Rok založení

2017

Uzávěrka

7/1/2021

Datum IPO

4/29/2021

Cena umístění

$16

Ziskovost

25.31%

O společnosti

Total Funding

$128.2M

Werewolf Therapeutics is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer.

Number of employees

11-50

Headquarters

Cambridge, Massachusetts, United States